Skip to content
10-Q

Quarterly Report

IDENIX PHARMACEUTICALS INC

0001193125-14-177107

← back to feed
Filed
May 1, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Apr 23, 2014 150.84M sh
Stock Issued Q1 2014 · Mar 31, 2014 16.4M sh
Capex Q1 2014 · Mar 31, 2014 $11K
Capex Q1 2014 · Mar 31, 2013 $249K
Cash And Equivalents Q1 2014 · Mar 31, 2014 $205.01M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $122.01M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $205.3M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $230.83M
Stockholders Equity Q1 2014 · Mar 31, 2014 $184.4M
Stockholders Equity Q1 2014 · Dec 31, 2013 $106M
Current Liabilities Q1 2014 · Mar 31, 2014 $21.93M
Current Liabilities Q1 2014 · Dec 31, 2013 $18.19M
Total Liabilities Q1 2014 · Mar 31, 2014 $38.73M
Total Liabilities Q1 2014 · Dec 31, 2013 $35.01M
Current Assets Q1 2014 · Mar 31, 2014 $211.9M
Current Assets Q1 2014 · Dec 31, 2013 $129.75M
Total Assets Q1 2014 · Mar 31, 2014 $223.13M
Total Assets Q1 2014 · Dec 31, 2013 $141.01M
Sga Expense Q1 2014 · Mar 31, 2014 $10.3M
Sga Expense Q1 2014 · Mar 31, 2013 $7.54M
Rd Expense Q1 2014 · Mar 31, 2014 $21.08M
Rd Expense Q1 2014 · Mar 31, 2013 $24.01M
Net Income Q1 2014 · Mar 31, 2014 −$34.11M
Net Income Q1 2014 · Mar 31, 2013 −$30.75M
Operating Income Q1 2014 · Mar 31, 2014 −$34.39M
Operating Income Q1 2014 · Mar 31, 2013 −$31.02M
Revenue Q1 2014 · Mar 31, 2014 −$3.01M
Revenue Q1 2014 · Mar 31, 2013 $852K
Cost Of Revenue Q1 2014 · Mar 31, 2013 $332K